| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.3 | 4e-12 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.31 | 5e-12 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.24 | 9e-07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.093 | 0.03 |